How the Institutional Review Board Shapes Ethical Research Today

Published

The institutional review board (IRB) stands as the cornerstone of ethical research—an independent body tasked with safeguarding human participants in studies. Without its oversight, scientific progress would risk exploitation, harm, or unchecked bias. Yet despite its critical role, many researchers and institutions still grapple with its complexities, from submission protocols to evolving regulatory demands.

Its influence extends beyond academia, shaping corporate trials, government-funded projects, and even private-sector innovation. A misstep in compliance can derail years of work, while adherence ensures credibility. The IRB’s decisions are not just bureaucratic hurdles; they reflect a broader societal trust in research integrity.

But how did this system emerge? Why does it operate the way it does? And what challenges lie ahead as science evolves?

institutional review board

The Complete Overview of the Institutional Review Board

The institutional review board (IRB) is the ethical watchdog of research involving human subjects, ensuring studies comply with federal, state, and institutional policies. Its authority derives from laws like the Common Rule (45 CFR 46) and the Helsinki Declaration, which mandate protection for participants from physical, psychological, or social harm. Without this layer of scrutiny, vulnerabilities—such as coercion, lack of informed consent, or disproportionate risk—could go unchecked.

IRBs operate under three core principles: respect for persons (autonomy and consent), beneficence (maximizing benefits, minimizing harm), and justice (fair participant selection). These principles are not abstract; they are enforced through rigorous review processes, from exempt studies to full-board evaluations. The board’s composition—typically including scientists, non-scientists, and community representatives—ensures diverse perspectives on ethical dilemmas.

Historical Background and Evolution

The modern IRB traces its origins to the Nuremberg Code (1947), born from the atrocities of Nazi medical experiments. This document established that voluntary consent and risk-benefit analysis were non-negotiable. Yet it wasn’t until the Tuskegee Syphilis Study (1932–1972)—where 600 Black men were denied treatment—that public outrage forced systemic change.

In 1974, the U.S. Department of Health, Education, and Welfare issued the National Research Act, creating the first federal IRB regulations. The Belmont Report (1979) later formalized the three ethical principles still guiding today’s institutional review boards. Over time, global standards aligned, with the World Medical Association’s Helsinki Declaration reinforcing IRB-like protections worldwide. Today, even private companies conducting user studies (e.g., tech firms analyzing app data) must navigate IRB-like oversight.

Core Mechanisms: How It Works

An IRB’s workflow begins with a protocol submission, where researchers detail methods, risks, consent procedures, and data handling. The board then classifies the study into one of three review tiers:
1. Exempt (minimal risk, e.g., anonymous surveys),
2. Expedited (procedures with standard risks, reviewed by a subcommittee),
3. Full-board (higher-risk studies requiring a full committee vote).

Table of Contents

Meetings are typically held monthly, with quorum requirements (e.g., at least five members, including one non-affiliated layperson). Approval isn’t automatic—boards may request modifications, such as strengthening consent forms or adding safeguards for vulnerable populations (e.g., children, prisoners). Continued oversight includes annual reviews and unanticipated problem reports to address emerging ethical concerns.

Key Benefits and Crucial Impact

The IRB system prevents ethical breaches that could erode public trust in science. Studies like the Jewish Chronic Disease Hospital Experiment (1963), where patients were injected with live cancer cells without consent, underscore the necessity of such safeguards. Today, IRBs act as a quality control mechanism, ensuring that research aligns with societal values while advancing knowledge.

Their impact is measurable: IRB-mandated consent processes reduce litigation risks, while risk-assessment frameworks protect participants from harm. Institutions with robust IRB compliance also benefit from enhanced funding eligibility and global collaboration opportunities, as many countries require IRB-equivalent reviews for international studies.

"The IRB is not just a regulatory checkbox—it’s the moral compass of research. Without it, innovation would outpace ethics, and science would lose its license to operate." — Dr. Henry Foster, Bioethics Professor, Johns Hopkins University

Major Advantages

  • Protection of Vulnerable Groups: IRBs enforce special protections for children, prisoners, and cognitively impaired individuals, ensuring their participation is truly voluntary and beneficial.
  • Risk Mitigation: By identifying potential harms (e.g., psychological distress in interviews), IRBs help researchers design safer studies and implement contingency plans.
  • Informed Consent Standardization: Mandated consent forms must use plain language, avoiding coercion and ensuring participants understand risks—reducing legal vulnerabilities for institutions.
  • Global Research Facilitation: Many countries (e.g., EU, Canada) recognize U.S. IRB approvals, streamlining international collaborations while maintaining ethical consistency.
  • Institutional Reputation Safeguard: High-profile ethical violations (e.g., Stanford Prison Experiment) can tarnish an institution’s legacy; IRBs act as a preemptive shield.

institutional review board - Ilustrasi 2

Comparative Analysis

Aspect Institutional Review Board (IRB) Ethics Committee (EC) / Research Ethics Board (REB)
Primary Focus Human subjects protection in research (U.S. federal mandate). Broader ethical oversight, including animal research and institutional policies (varies by country).
Regulatory Basis 45 CFR 46 (Common Rule), HHS guidelines. Country-specific laws (e.g., UK’s Research Governance Framework, EU’s GDPR for data privacy).
Composition Scientists, non-scientists, community members (U.S. requirement). Varies; may include philosophers, legal experts, or public representatives.
Review Speed Expedited reviews can take weeks; full-board reviews may take months. Depends on jurisdiction; some ECs use tiered systems similar to IRBs.
As research evolves, so do the challenges for institutional review boards. Big data and AI present new ethical dilemmas: How do IRBs assess risks in studies using de-identified datasets? The rise of global clinical trials also demands harmonized standards, as local IRBs may interpret risks differently. Innovations like predictive ethics reviews—using algorithms to flag potential ethical red flags—could streamline processes, but raise questions about bias in automated decisions.

Another frontier is participant engagement: IRBs are increasingly involving communities in protocol design, moving beyond passive oversight to collaborative ethics. However, balancing speed (e.g., rapid COVID-19 vaccine trials) with thorough review remains a tension point. The future may lie in hybrid models, combining traditional IRB rigor with adaptive, real-time ethical monitoring.

institutional review board - Ilustrasi 3

Conclusion

The institutional review board is more than a procedural hurdle—it’s the linchpin of ethical research. Its existence ensures that scientific progress does not come at the cost of human dignity. While critics argue IRBs can slow innovation, their role in preventing scandals like Milgram’s obedience experiments or Wenham’s unethical cancer trials is undeniable.

As research becomes more complex, IRBs must adapt without compromising their core mission. The balance between rigor and agility will define their relevance in an era of exponential scientific advancement. One thing is certain: without institutional review boards, the trust that fuels research would erode—and with it, the progress they were designed to protect.

Comprehensive FAQs

Q: What types of studies require IRB approval?

Any research involving human subjects—whether data collection, interviews, clinical trials, or even observational studies—requires IRB review if it meets federal definitions of "research" and "human subject." Exemptions apply to minimal-risk studies (e.g., public surveys with no identifiers).

Q: How long does the IRB approval process take?

Timelines vary: expedited reviews may take 2–4 weeks, while full-board reviews can take 6–12 weeks or longer, depending on protocol complexity and board workload. Some institutions offer "fast-track" options for urgent studies (e.g., public health crises).

Q: Can an IRB reject a study outright?

Yes. If a study poses unacceptable risks, lacks valid scientific merit, or fails to meet ethical standards (e.g., inadequate consent), the IRB can deny approval. Researchers must then revise the protocol and resubmit.

Q: Do international studies need both local and U.S. IRB approvals?

Typically, yes. Many countries require local ethics committee approval in addition to U.S. IRB review for international collaborations. Some institutions use central IRBs to streamline multi-site studies, but local oversight is often mandatory.

Q: What happens if a study violates IRB guidelines after approval?

Unanticipated problems must be reported to the IRB immediately. Violations can lead to suspension of the study, loss of funding, or institutional sanctions. Severe cases may result in legal consequences, especially if harm occurs.

Q: How do IRBs handle conflicts of interest?

IRBs require members to disclose potential conflicts (e.g., financial ties to the study sponsor). If a conflict arises during review, the member may recuse themselves, and the board votes without their input. Some institutions also mandate external reviewers for high-risk studies.

Q: Are there IRB alternatives for low-risk research?

Yes. Some institutions use ethics advisory boards or streamlined review processes for minimal-risk studies (e.g., secondary data analysis). However, even these often require documentation to demonstrate compliance with ethical standards.

Q: How do IRBs ensure diversity in participant selection?

IRBs review recruitment strategies to avoid exclusionary practices (e.g., targeting only convenient populations). They may require justification for underrepresented groups and assess whether risks/benefits are equitably distributed across demographics.

Q: Can students or early-career researchers navigate the IRB process alone?

While possible, it’s strongly advised to collaborate with experienced mentors or institutional research offices. Many universities offer IRB workshops, and some provide pre-submission reviews to improve approval odds.

Q: What’s the difference between an IRB and an IACUC?

An IRB oversees human subjects research, while an IACUC (Institutional Animal Care and Use Committee) regulates animal studies. Both ensure ethical treatment but apply to entirely different domains under separate federal guidelines.